Equities

MyHealthChecked PLC

MyHealthChecked PLC

Actions
  • Price (EUR)0.087
  • Today's Change0.00 / 0.00%
  • Shares traded-1.00
  • 1 Year change-59.04%
  • Beta--
Data delayed at least 15 minutes, as of May 16 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

MyHealthChecked PLC is a United Kingdom-based consumer home-testing healthcare company. The Company is the umbrella brand of a range of at-home rapid tests, as well as deoxyribonucleic acid (DNA), ribonucleic acid (RNA) and blood sample collection kits. The Company also provides COVID tests. The Company's multi-platform portfolio of tests offers users access to a variety of test types, sample collection options, and levels of analysis, enabling it to meet diverse customer needs. The tests are lateral-flow self-tests, whilst the sample collection kits enable the collection of blood, urine, nasal or mouth swab samples that are analyzed in partner laboratories for a range of biomarkers. The tests have been made available online and for over-the-counter purchase. All its business activity is underpinned by two distinct routes to market: business to business to consumer (B2B2C) and direct to consumer.

  • Revenue in GBP (TTM)14.95m
  • Net income in GBP189.00k
  • Incorporated2008
  • Employees15.00
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.